MACEJOVA, Dana, Jakub KOLLAR, Pavel BOBÁĽ, Jan OTEVŘEL, Daniela SCHUSTER a Julius BRTKO. Triphenyltin isoselenocyanate: a novel nuclear retinoid X receptor ligand with antiproliferative and cytotoxic properties in cell lines derived from human breast cancer. Molecular and Cellular Biochemistry. DORDRECHT: Springer, 2024, Neuvedeno, Neuvedeno, s. 1-16. ISSN 0300-8177. Dostupné z: https://dx.doi.org/10.1007/s11010-023-04914-w.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Triphenyltin isoselenocyanate: a novel nuclear retinoid X receptor ligand with antiproliferative and cytotoxic properties in cell lines derived from human breast cancer
Autoři MACEJOVA, Dana (703 Slovensko), Jakub KOLLAR (203 Česká republika), Pavel BOBÁĽ (703 Slovensko, domácí), Jan OTEVŘEL (203 Česká republika, domácí), Daniela SCHUSTER (40 Rakousko) a Julius BRTKO (703 Slovensko).
Vydání Molecular and Cellular Biochemistry, DORDRECHT, Springer, 2024, 0300-8177.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30104 Pharmacology and pharmacy
Stát vydavatele Nizozemské království
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 4.300 v roce 2022
Organizační jednotka Farmaceutická fakulta
Doi http://dx.doi.org/10.1007/s11010-023-04914-w
UT WoS 001150933100001
Klíčová slova anglicky Triorganotin isoselenocyanates; Retinoid X receptor; Apoptosis; Breast cancer
Štítky rivok, ÚChL
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Daniela Černá, učo 489184. Změněno: 20. 5. 2024 14:42.
Anotace
Several commercially available triorganotin compounds were previously found to function as agonist ligands for nuclear retinoid X receptor (RXR) molecules. Triphenyltin isoselenocyanate (TPT-NCSe), a novel selenium atom containing a derivative of triorganotin origin, was found to represent a new cognate bioactive ligand for RXRs. TPT-NCSe displayed a concentration- and time-dependent decrease in the cell viability in both human breast carcinoma MCF-7 (estrogen receptor positive) and MDA-MB-231 (triple negative) cell lines. Reactive oxygen species levels generated in response to TPT-NCSe were significantly higher in both carcinoma cell lines treated with TPT-NCSe when compared to mock-treated samples. Treatment with 500 nM TPT-NCSe caused a decrease in SOD1 and increased SOD2 mRNA in MCF-7 cells. The levels of SOD2 mRNA were more increased following the treatment with TPT-NCSe along with 1 mu M all-trans retinoic acid (AtRA) in MCF-7 cells. An increased superoxide dismutase SOD1 and SOD2 mRNA levels were also detected in combination treatment of 500 nM TPT-NCSe and 1 mu M AtRA in TPT-NCSe-treated MDA-MB-231 cells. The data have also shown that TPT-NCSe induces apoptosis via a caspase cascade triggered by the mitochondrial apoptotic pathway. TPT-NCSe modulates the expression levels of apoptosis-related proteins, Annexin A5, Bcl-2 and BAX family proteins, and finally, it enhances the expression levels of its cognate nuclear receptor subtypes RXRalpha and RXRbeta.
VytisknoutZobrazeno: 18. 7. 2024 01:39